Important Safety InformationFull Prescribing Information|Contact Us|Healthcare Professional Site
This site is intended for US patients only.
Sign up to receive tips and tools
Home

Paying for Treatment

Jim, diagnosed with multiple myeloma
Watch Video 5:46

Understanding the insurance coverage process

The insurance verification process can be complicated, and that’s why Millennium, maker of VELCADE® (bortezomib), is here to help. In this section, you’ll find tips to help you understand the coverage process and how to get financial access to VELCADE.

At any time during your treatment, contact a dedicated VELCADE case manager from 8 am to 8 pm ET, Monday through Friday at 1-866-VELCADE (835-2233), option 2.

OPEN ALL TABS CLOSE ALL TABS PRINT

Step 1: Talk with your doctor

If you have any questions about treatment and how it might impact your out-of-pocket expenses, talk with your doctor and the office staff.

They’re a resource for knowing what to expect from your treatment and how insurance coverage may impact different treatment regimens. They can also refer you to other useful resources.

Step 2: Provide insurance information to your doctor’s office

Make sure that your doctor's office has all of your current insurance information. They’ll need to verify your coverage and provide your insurance company with treatment information.

Your doctor's office will research your insurance coverage to determine if VELCADE (bortezomib) will be covered. They’ll also check whether other documents will be needed and how much you will need to pay for your treatment.

  • If your insurance company covers VELCADE, you will move on to the payment and scheduling processes outlined in steps 3 and 4.
  • If your insurance company requests more information, your doctor may need to submit a letter that states the reason(s) why you need to be treated with VELCADE. The insurance company will notify both you and the doctor about its decision. If coverage is approved, you will move on to the payment and scheduling processes outlined in steps 3 and 4.
  • If your insurance company requests more information and does not approve your treatment based on what your doctor has provided, then you may be able to get assistance through the VELCADE Reimbursement Assistance Program (VRAP)

Step 3: Understand the payment process

Depending on the details of your insurance coverage, your out-of-pocket expense will vary. It is important to understand these details and to know where you can go for help.

Following the insurance verification process, you and your doctor's office will know whether you have coverage for your treatment with VELCADE (bortezomib). You’ll also know how much you will be responsible for paying, according to your insurance policy.

Insured

If your insurance company covers VELCADE and you have either a supplemental policy or can self-pay to cover the co-payment, then treatment will begin as soon as it can be scheduled.

Underinsured

If you are unable to afford your co-payment, then you can apply to a co-payment foundation for assistance. You will need to fill out an enrollment form in order to be evaluated for assistance by the foundation. Case managers from the VELCADE Reimbursement Assistance Program (VRAP) can help you identify the foundations that cover your diagnosis, and they can assist you with the form.

Your doctor's office may also be able to help you with this process. If you are approved for assistance from the co-payment foundation, the foundation will notify you of the amount they will give you for your treatment.

Uninsured

If you have no insurance coverage, you may be eligible for the VELCADE Patient Assistance Program (VPAP). You or your doctor's office can call VPAP for a prescreening to see if you qualify for the program. You and your doctor will have to fill out a 1-page form, provide financial documentation, and fax the information to VPAP. Within 48 hours, you will know whether you can get the medication free for your treatment.

For more information about the VELCADE Patient Assistance Program, click here.

Step 4: Schedule your treatment

Once you have determined how you will be able to pay for VELCADE (bortezomib), contact your doctor's office to schedule your treatment.

Once your insurance coverage for VELCADE has been verified, you will set up an appointment to receive your therapy. VELCADE is given as a subcutaneous shot (under the skin), usually into your abdomen or thigh. VELCADE can also be given as a 3- to 5-second intravenous (IV) injection into a vein. Both ways are given in your doctor’s office or clinic.

Need additional resources?

Other resources can assist you and your caregiver throughout treatment. These resources can provide assistance with treatment costs, identifying support groups for you and other family members, and partnering with your doctor and insurance company to get treatment coverage.

For a listing of additional resources, click here.

If you have any questions about paying for treatment or understanding your insurance coverage, we may be able to help. Call 1-866-VELCADE, option 2.
A VELCADE case manager is available to you between the hours of 8 am and 8 pm (ET), Monday through Friday
Next: Co-pay Resources

Resources

Paying for Treatment

Find out how the makers of VELCADE (bortezomib) may be able to help.

Learn more

Understanding your treatment schedule

Use this interactive tool to track your treatment schedule.

Get started

Join the Patient Support Program for VELCADE, and receive helpful tools, resources, and support

Contact us

VELCADE INFO LINE: 1-866-835-2233

Indications and Important Safety Information for VELCADE® (bortezomib)

What is VELCADE used for?

VELCADE (bortezomib) is approved for the treatment of patients with multiple myeloma (a cancer of the plasma cells). VELCADE is also approved for the treatment of patients with mantle cell lymphoma (a cancer of the lymph nodes) who have already received other treatments.

How is VELCADE administered?

VELCADE is prescribed by a physician experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously, or IV) or under your skin (subcutaneously). VELCADE must not be administered into your spinal fluid (intrathecally).

Who should not receive VELCADE?

Before you receive treatment with VELCADE, tell your doctor about all of your medical conditions. You should not receive VELCADE if you are allergic to bortezomib, boron, or mannitol.

What are the possible side effects of VELCADE?

VELCADE (bortezomib) can cause serious side effects, including:

  • Peripheral neuropathy. VELCADE can cause damage to the nerves, a condition called peripheral neuropathy. You may feel muscle weakness, tingling, burning, pain, and loss of feeling in your hands and feet, any of which can be severe. Tell your doctor if you notice any of these symptoms. Your doctor may change the dose and/or schedule of VELCADE or stop it altogether. If you have peripheral neuropathy before starting VELCADE, your doctor could consider giving you VELCADE subcutaneously.
  • Low blood pressure. VELCADE can cause a drop in blood pressure. Tell your doctor if you have low blood pressure, feel dizzy, or feel as though you might faint. If you are taking drugs that lower blood pressure, your medications might need to be adjusted. If you are not drinking enough liquids, your doctor may need to administer IV fluids.
  • Heart problems. Treatment with VELCADE can cause or worsen heart rhythm problems and heart failure. Your doctor may closely monitor you if you have, or are at risk for, heart disease. Tell your doctor if you experience chest pressure or pain, palpitations, swelling of your ankles or feet, or shortness of breath.
  • Lung problems. There have been reports of lung disorders in patients receiving VELCADE. Some of these events have been fatal. Tell your doctor if you experience any cough, shortness of breath, wheezing, or difficulty breathing.
  • Liver problems. If you have liver problems, it can be harder for your body to get rid of VELCADE. VELCADE has caused sudden liver failure in patients who were taking many medications or had other serious medical conditions. Symptoms of liver problems include a yellow discoloration of the eyes and skin (jaundice) and changes in liver enzymes measured in blood tests. Your doctor will closely monitor you if you have liver disease.
  • Posterior reversible encephalopathy syndrome (PRES). There have been reports of a rare, reversible condition involving the brain, called PRES, in patients treated with VELCADE. Patients with PRES can have seizures, high blood pressure, headaches, tiredness, confusion, blindness, or other vision problems. Treatment with VELCADE should be stopped in cases of PRES.
  • Gastrointestinal problems. VELCADE (bortezomib) treatment can cause nausea, vomiting, diarrhea, and constipation. If your symptoms are severe, your doctor may recommend IV fluids and/or medications.
  • Neutropenia (low levels of neutrophils, a type of white blood cell). VELCADE can cause low levels of white blood cells (infection-fighting cells). If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.
  • Thrombocytopenia (low levels of platelets). VELCADE can cause low levels of platelets (clot-forming cells). If platelets become very low, there is an increased risk of bleeding. Your doctor may recommend a platelet transfusion.
    You will have regular blood tests to check your cell counts during your treatment with VELCADE. If the number of these cells is very low, your doctor may change the dose and/or schedule of VELCADE.
  • Tumor lysis syndrome (TLS). TLS is a syndrome that causes a chemical imbalance in the blood that could lead to heart and/or kidney problems. TLS can occur with cancer treatments, and your doctor will be monitoring your blood and urine for any signs of this syndrome. If you develop TLS, your doctor will take appropriate steps to treat it.

More than 1 in 5 patients (20%) receiving VELCADE have experienced the following side effects: nausea, diarrhea, thrombocytopenia, neutropenia, peripheral neuropathy, fatigue, neuralgia (nerve pain), anemia, leukopenia (low levels of white blood cells), constipation, vomiting, lymphopenia (low levels of a certain type of white blood cells), rash, pyrexia (fever), and anorexia.

What other information should you discuss with your doctor?

Women should avoid becoming pregnant or breast-feeding while being treated with VELCADE (bortezomib). Discuss with your doctor when it is safe to restart breast-feeding after finishing your treatment.

You should also tell your doctor if you:

  • Have kidney disease. If you are on dialysis, your doctor will administer VELCADE after the dialysis procedure.
  • Are taking medication for diabetes. VELCADE can affect your blood glucose levels. Your doctor may require close monitoring of your blood glucose levels and change the dose of your diabetes medicine while you are being treated with VELCADE.
  • Have liver disease.
  • Are using any other medications, including prescription and over-the-counter drugs, herbal or dietary supplements, or holistic treatments. St. John’s wort should be avoided.
  • Develop a rash of any type while receiving VELCADE.

The side effects of VELCADE may impair your ability to drive or operate machinery.

These are not all of the possible side effects with VELCADE. It is important to always contact your doctor if you experience any side effects while on VELCADE. If you have any questions about VELCADE, contact your doctor. Additional information is available on the Web site VELCADE.com.

Please see the full Prescribing Information for VELCADE, including Warnings and Precautions.

VELCADE® (bortezomib) Information Line: 1-866-835-2233
Terms of Use | Privacy Policy | Contact Us | Millennium.com | Unsubscribe
© 2013 Millennium Pharmaceuticals, Inc. A wholly-owned subsidiary of Takeda Pharmaceutical Company Limited       V-12-0386 02/13